40% højere plasmaeksponering for valdecoxib til følge, sammenlignet med raske, unge forsøgspersoner.
In healthy elderly subjects, the apparent oral clearance of valdecoxib was reduced, resulting in an approximately 40% higher plasma exposure of valdecoxib compared to healthy young subjects.